top of page

Transforming MRI to better detect early stages of disease

Discover the Future of Non-Invasive Digital Biopsy

Introducing
Magnetic Resonance  Histopathology
(MRH)

MRH is a novel MRI based software method that non-invasively measures tissue texture at the micro level  (sub 1mm).  MRH is a valuable tool to help Radiologist detect signs of early cancer or other diseases and potentially will lead to a safer, less invasive, more accurate, and less costly alternative to the routine practice of surgical biopsies. This advancement could possibly allow for earlier detection of many diseases and cancers and enable more accurate therapies sooner in the disease cycle to improve patient outcomes and lower medical costs.

inject-online-programs-service_1725637934774.png

Benefits of 
Magnetic Resonance  Histopathology (MRH)

Proprietary MRI Pulse Sequence 

Our proprietary MRI Pulse sequence signal captures novel data about the tissue microarchitecture by targeting specific spatial wavelengths, providing unparalleled insight into tissue texture and structural differences for more accurate diagnosis.

Compatible with DICOM Protocols

MRH data is fully compatible with DICOM protocols, ensuring seamless integration with existing medical imaging workflows for efficient data transfer, storage, and analysis across any DICOM-compliant platforms and to the BioProtonics Cloud where AI Analytics is accessed.

Little Time Added to Your Existing MRI Scan

MRH protocol is designed to seamlessly integrate into a standard MRI exam with minimal impact on scan duration. The process adds as little as 90 seconds to the overall procedure, making it a highly efficient, without significantly extending the patient's time in the scanner.

 Digital Biopsy with Advanced AI Analysis

Our advanced AI analysis compares MRH data like a Digital Biopsy comparing with ground truth biopsy results to enhance early diagnosis by identifying subtle differences in tissue structure. This comparison ensures highly accurate detection of abnormalities, helping clinicians diagnose diseases at an earlier stage for more effective intervention.

Advancing MRI Technology & Capability

90M

MRI Scans Worldwide per Year

45K

MRI Machines Worldwide

30M

MRI Scans in the USA per Year

1M

MRI Scans for Prostate Cancer Screening

40%

False Negative Results  with Prostate Biopsys

bottom of page